{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:33Z","timestamp":1786120233406,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/wno.0b013e318241da45","type":"journal-article","created":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T05:04:29Z","timestamp":1327035869000},"page":"54-57","source":"Crossref","is-referenced-by-count":19,"title":["Is Leber Hereditary Optic Neuropathy Treatable? Encouraging Results With Idebenone in Both Prospective and Retrospective Trials and An Illustrative Case"],"prefix":"10.1097","volume":"32","author":[{"given":"Esfandiar J.","family":"Sabet-Peyman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khizer R.","family":"Khaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo A.","family":"Sadun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210126","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Lebers hereditary optic neuropathy.","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"R3-14-20210126","first-page":"10","article-title":"Visual recovery in patients with Lebers hereditary optic neuropathy and the 11778 mutation.","volume":"12","author":"Stone","year":"1992","journal-title":"J Clin Neuroophthalmol"},{"key":"R4-14-20210126","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ophtha.2009.07.026","article-title":"Natural history of Lebers hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography.","volume":"117","author":"Barboni","year":"2010","journal-title":"Ophthalmology"},{"key":"R5-14-20210126","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","article-title":"The neuro-ophthalmology of mitochondrial disease.","volume":"55","author":"Fraser","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"R6-14-20210126","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies.","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"R7-14-20210126","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.3201231","article-title":"Mitochondrial DNA mutation associated with Lebers hereditary optic neuropathy.","volume":"242","author":"Wallace","year":"1988","journal-title":"Science"},{"key":"R8-14-20210126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1096-7192(02)00145-2","article-title":"Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits.","volume":"77","author":"Geromel","year":"2002","journal-title":"Mol Genet Metab"},{"key":"R9-14-20210126","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11940-010-0100-y","article-title":"Lebers hereditary optic neuropathy.","volume":"13","author":"Sadun","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"R10-14-20210126","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/WNO.0b013e31818f138f","article-title":"Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year.","volume":"28","author":"Sadun","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"R11-14-20210126","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1016\/j.bmcl.2011.04.085","article-title":"Alpha-tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.","volume":"21","author":"Shrader","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"R12-14-20210126","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0140-6736(92)91442-B","article-title":"Remission of Lebers hereditary optic neuropathy with idebenone.","volume":"340","author":"Mashima","year":"1992","journal-title":"Lancet"},{"key":"R14-14-20210126","first-page":"1440","article-title":"Idebenone treatment in patients with Leber hereditary optic neuropathy.","volume":"50","author":"Eng","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-14-20210126","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/brain\/awr192","article-title":"Treatment of Leber hereditary optic neuropathy.","volume":"134","author":"Newman","year":"2011","journal-title":"Brain"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNO.0b013e318241da45","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:30:06Z","timestamp":1786048206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041327-201203000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e318241da45","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}